ArticleOncogene2022

Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancer.

Jashodeep Datta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.